| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.CANLET.2006.11.005 |
| P698 | PubMed publication ID | 17166655 |
| P50 | author | Giuseppe Biamonti | Q42716224 |
| Alessandra Montecucco | Q54877932 | ||
| P2093 | author name string | Giuseppe Biamonti | |
| Alessandra Montecucco | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | etoposide | Q418817 |
| P304 | page(s) | 9-18 | |
| P577 | publication date | 2006-12-12 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Cellular response to etoposide treatment | |
| P478 | volume | 252 |
| Q39721119 | 5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis |
| Q89532437 | A CRISPR/Cas13-based approach demonstrates biological relevance of vlinc class of long non-coding RNAs in anticancer drug response |
| Q33708985 | A novel aminosteroid of the 5α-androstane-3α,17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells |
| Q35571888 | A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide |
| Q37628142 | A role for XLF in DNA repair and recombination in human somatic cells |
| Q28488243 | A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays |
| Q35742838 | A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. |
| Q39017717 | A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments. |
| Q52373680 | ATLANTIS - Attractor Landscape Analysis Toolbox for Cell Fate Discovery and Reprogramming. |
| Q53169706 | ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damage. |
| Q35966249 | Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase. |
| Q39972640 | Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis |
| Q28476505 | An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II |
| Q38549117 | Anthracyclines induce DNA damage response-mediated protection against severe sepsis. |
| Q33793023 | Anti-cancer agents in Saudi Arabian herbals revealed by automated high-content imaging |
| Q52595313 | BRD4 facilitates replication stress-induced DNA damage response. |
| Q52682205 | Biological evaluation of octahydropyrazin[2,1-a:5,4-a']diisoquinoline derivatives as potent anticancer agents. |
| Q36206479 | Cell cycle control in acute myeloid leukemia. |
| Q34223777 | Changes in DNA methylation and transgenerational mobilization of a transposable element (mPing) by the topoisomerase II inhibitor, etoposide, in rice |
| Q28542976 | Compound A398, a novel podophyllotoxin analogue: cytotoxicity and induction of apoptosis in human leukemia cells |
| Q42704196 | CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1. |
| Q45986603 | Cytotoxicity and mitochondrial apoptosis induced by etoposide in melanoma cells. |
| Q38751724 | Cytotoxicity, Post-Treatment Recovery, and Selectivity Analysis of Naturally Occurring Podophyllotoxins from Bursera fagaroides var. fagaroides on Breast Cancer Cell Lines. |
| Q34783261 | DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control |
| Q39882856 | DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression. |
| Q39964024 | Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells. |
| Q36882127 | Development and evaluation of sustained-release etoposide-loaded poly(ε-caprolactone) implants |
| Q39148112 | Differential effect of hypoxia on etoposide-induced DNA damage response and p53 regulation in different cell types |
| Q42822867 | Discovery of a new bioactive molecule for neuroblastoma |
| Q33688244 | Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma. |
| Q55512207 | Double Strand Break DNA Repair occurs via Non-Homologous End-Joining in Mouse MII Oocytes. |
| Q39316013 | Dual effect of heat shock on DNA replication and genome integrity. |
| Q34894253 | Dynamics of double strand breaks and chromosomal translocations |
| Q34483120 | ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation |
| Q47429450 | Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia. |
| Q36100739 | Etoposide damages female germ cells in the developing ovary. |
| Q27300740 | Etoposide induces nuclear re-localisation of AID |
| Q42737898 | Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies |
| Q34625676 | Evidence for involvement of cytosolic thioredoxin peroxidase in the excessive resistance of Sf9 Lepidopteran insect cells against radiation-induced apoptosis |
| Q41905881 | GL3, a Novel 4β-Anilino-4'-O-Demethyl-4-Desoxypodophyllotoxin Analog, Traps Topoisomerase II Cleavage Complexes and Exerts Anticancer Activities. |
| Q38051016 | High-dose etoposide in allogeneic stem cell transplantation |
| Q28484877 | Hypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell types |
| Q35059927 | Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening. |
| Q47097943 | Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines |
| Q39104031 | Impact of cell cycle delay on micronucleus frequency in TK6 cells |
| Q57214335 | In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment |
| Q38777016 | Interfacing antibody-based microarrays and digital holography enables label-free detection for loss of cell volume |
| Q90448516 | Kaempferol derivatives isolated from Lens culinaris Medik. reduce DNA damage induced by etoposide in peripheral blood mononuclear cells |
| Q37019406 | Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins |
| Q34582160 | MCL-1 localizes to sites of DNA damage and regulates DNA damage response |
| Q39956353 | Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress |
| Q34081938 | Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants. |
| Q47142346 | MiR-302a sensitizes leukemia cells to etoposide by targeting Rad52. |
| Q34896154 | Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors |
| Q37260555 | Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents |
| Q34459467 | NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells |
| Q90570989 | Northern lights assay: a versatile method for comprehensive detection of DNA damage |
| Q39749118 | Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents |
| Q36613874 | Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions |
| Q92298803 | PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes |
| Q28550394 | Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells |
| Q24657508 | Plk1-dependent and -independent roles of an ODF2 splice variant, hCenexin1, at the centrosome of somatic cells |
| Q36094083 | Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy |
| Q42774030 | Prenatal exposure to flavonoids: implication for cancer risk |
| Q95853372 | Preparation and Biopharmaceutical Evaluation of Novel Polymeric Nanoparticles Containing Etoposide for Targeting Cancer Cells |
| Q36975842 | Processing of nonconventional DNA strand break ends |
| Q54260671 | Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context. |
| Q53219322 | QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells. |
| Q36103898 | Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage |
| Q33398834 | RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells |
| Q50083405 | Recombinant human erythropoietin prevents etoposide- and methotrexate-induced toxicity in kidney and liver tissues via the regulation of oxidative damage and genotoxicity in Wistar rats |
| Q39435616 | Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II. |
| Q35861281 | Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. |
| Q26798149 | SAM68: Signal Transduction and RNA Metabolism in Human Cancer |
| Q39716863 | Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy. |
| Q35924384 | The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. |
| Q42424833 | The anticancer natural product ophiobolin A induces cytotoxicity by covalent modification of phosphatidylethanolamine |
| Q28115800 | The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells |
| Q34175350 | The dynamics of DNA topoisomerase IIalpha in living cells |
| Q87851103 | The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/-) and TP53(-/-) cells |
| Q38827517 | The skeletal impact of the chemotherapeutic agent etoposide |
| Q38268221 | Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms. |
| Q33350077 | Topoisomerase II inhibition involves characteristic chromosomal expression patterns |
| Q41130676 | Topoisomerase IIalpha-dependent induction of a persistent DNA damage response in response to transient etoposide exposure. |
| Q42746156 | Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells |
| Q28082910 | Trial Watch: Proteasomal inhibitors for anticancer therapy |
| Q26745686 | Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy |
| Q26745673 | Trial watch - inhibiting PARP enzymes for anticancer therapy |
| Q41563902 | XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma |
| Q35503066 | p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression |
Search more.